{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:15:45Z","timestamp":1773281745985,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:00:00Z","timestamp":1613088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nasal High Flow (NHF) therapy delivers flows of heated humidified gases up to 60 LPM (litres per minute) via a nasal cannula. Particles of oral\/nasal fluid released by patients undergoing NHF therapy may pose a cross-infection risk, which is a potential concern for treating COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Liquid particles within the exhaled breath of healthy participants were measured with two protocols: (1) high speed camera imaging and counting exhaled particles under high magnification (6 participants) and (2) measuring the deposition of a chemical marker (riboflavin-5-monophosphate) at a distance of 100 and 500 mm on filter papers through which air was drawn (10 participants). The filter papers were assayed with HPLC. Breathing conditions tested included quiet (resting) breathing and vigorous breathing (which here means nasal snorting, voluntary coughing and voluntary sneezing). Unsupported (natural) breathing and NHF at 30 and 60 LPM were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:list list-type=\"order\">\n                      <jats:list-item>\n                        <jats:p>Imaging: During quiet breathing, no particles were recorded with unsupported breathing or 30 LPM NHF (detection limit for single particles 33 \u03bcm). Particles were detected from 2 of 6 participants at 60 LPM quiet breathing at approximately 10% of the rate caused by unsupported vigorous breathing. Unsupported vigorous breathing released the greatest numbers of particles. Vigorous breathing with NHF at 60 LPM, released half the number of particles compared to vigorous breathing without NHF.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          Chemical marker tests: No oral\/nasal fluid was detected in quiet breathing without NHF (detection limit 0.28 \u03bcL\/m\n                          <jats:sup>3<\/jats:sup>\n                          ). In quiet breathing with NHF at 60 LPM, small quantities were detected in 4 out of 29 quiet breathing tests, not exceeding 17 \u03bcL\/m\n                          <jats:sup>3<\/jats:sup>\n                          . Vigorous breathing released 200\u20131000 times more fluid than the quiet breathing with NHF. The quantities detected in vigorous breathing were similar whether using NHF or not.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>During quiet breathing, 60 LPM NHF therapy may cause oral\/nasal fluid to be released as particles, at levels of tens of \u03bcL per cubic metre of air. Vigorous breathing (snort, cough or sneeze) releases 200 to 1000 times more oral\/nasal fluid than quiet breathing (p &lt; 0.001 with both imaging and chemical marker methods). During vigorous breathing, 60 LPM NHF therapy caused no statistically significant difference in the quantity of oral\/nasal fluid released compared to unsupported breathing. NHF use does not increase the risk of dispersing infectious aerosols above the risk of unsupported vigorous breathing. Standard infection prevention and control measures should apply when dealing with a patient who has an acute respiratory infection, independent of which, if any, respiratory support is being used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>ACTRN12614000924651<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0246123","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T16:25:52Z","timestamp":1613147152000},"page":"e0246123","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Assessment of dispersion of airborne particles of oral\/nasal fluid by high flow nasal cannula therapy"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-7570","authenticated-orcid":true,"given":"M. C.","family":"Jermy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J. T.","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kirton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kabaliuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hockey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Zulkhairi Abidin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-5223","authenticated-orcid":true,"given":"P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Mahaliyana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,2,12]]},"reference":[{"issue":"23","key":"pone.0246123.ref001","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"JP Frat","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0246123.ref002","first-page":"563","article-title":"High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"45","author":"B Rochwerg","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0246123.ref003","first-page":"e3201","article-title":"Aerosol-generating procedures and risk of transmission of acute respiratory infections: a systematic review","volume":"3","author":"K Tran","year":"2013","journal-title":"CADTH Technol Overv"},{"issue":"5","key":"pone.0246123.ref004","doi-asserted-by":"crossref","first-page":"e10717","DOI":"10.1371\/journal.pone.0010717","article-title":"Risk Factors for SARS Transmission from Patients Requiring Intubation: A Multicentre Investigation in Toronto, Canada","volume":"5","author":"J Raboud","year":"2010","journal-title":"PLoS ONE"},{"key":"pone.0246123.ref005","article-title":"Airborne or droplet precautions for health workers treating COVID-19?","author":"P Bahl","year":"2020","journal-title":"J Infect Dis"},{"key":"pone.0246123.ref006","doi-asserted-by":"crossref","first-page":"F2","DOI":"10.1017\/jfm.2020.330","article-title":"The flow physics of COVID-19","volume":"894","author":"R. Mittal","year":"2020","journal-title":"Journal of Fluid Mechanics"},{"key":"pone.0246123.ref007","article-title":"Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review","author":"NM Wilson","year":"2020","journal-title":"Anaesthesia"},{"issue":"1","key":"pone.0246123.ref008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12879-019-3707-y","article-title":"Recognition of aerosol transmission of infectious agents: a commentary","volume":"19","author":"R Tellier","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pone.0246123.ref009","doi-asserted-by":"crossref","unstructured":"Lefebvre, A.H., \u201cAtomization and Sprays\u201d, Taylor and Francis, 1989, ISBN 9780891166030","DOI":"10.1201\/9781482227857"},{"key":"pone.0246123.ref010","article-title":"Mechanisms of nasal high flow on ventilation during wakefulness and sleep","author":"T Mundel","year":"2013","journal-title":"J Appl Physiol"},{"key":"pone.0246123.ref011","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00348-010-0984-z","article-title":"Stereoscopic PIV measurements of flow in the nasal cavity with high flow therapy","volume":"50","author":"CJT Spence","year":"2010","journal-title":"Experiments in Fluids"},{"key":"pone.0246123.ref012","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00348-011-1044-z","article-title":"Unsteady flow in the nasal cavity with high flow therapy measured by stereoscopic PIV","volume":"52","author":"CJT Spence","year":"2012","journal-title":"Experiments in Fluids"},{"key":"pone.0246123.ref013","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41591-020-0843-2","article-title":"Respiratory virus shedding in exhaled breath and efficacy of face masks","volume":"26","author":"N.H.L. Leung","year":"2020","journal-title":"Nat Med"},{"key":"pone.0246123.ref014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41586-020-2271-3","article-title":"Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals","volume":"582","author":"Y. Liu","year":"2020","journal-title":"Nature"},{"key":"pone.0246123.ref015","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1038\/s41467-020-16670-2","article-title":"Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients","volume":"11","author":"P.Y. Chia","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"pone.0246123.ref016","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaerosci.2011.07.009","article-title":"Modality of human expired aerosol size distributions","volume":"42","author":"GR Johnson","year":"2011","journal-title":"Journal of Aerosol Science"},{"key":"pone.0246123.ref017","article-title":"Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering","author":"P Anfinrud","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0246123.ref018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhin.2018.10.007","article-title":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial","volume":"101","author":"CCH Leung","year":"2019","journal-title":"J Hosp Infect"},{"issue":"Suppl 4","key":"pone.0246123.ref019","first-page":"9","article-title":"Aerosol dispersion during various respiratory therapies: a risk assessment model of nosocomial infection to health care workers","volume":"20","author":"DS Hui","year":"2014","journal-title":"Hong Kong Med J"},{"issue":"4","key":"pone.0246123.ref020","doi-asserted-by":"crossref","first-page":"1802339","DOI":"10.1183\/13993003.02339-2018","article-title":"Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks","volume":"53","author":"DS Hui","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0246123.ref021","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhin.2019.11.010","article-title":"Assessment of the potential for pathogen dispersal during high-flow nasal therapy","volume":"104","author":"M Kotoda","year":"2020","journal-title":"J Hosp Infect"},{"key":"pone.0246123.ref022","first-page":"1","article-title":"The impact of high-flow nasal cannula (HFNC) on coughing distance: implications on its use during the novel coronavirus disease outbreak","author":"NW Loh","year":"2020","journal-title":"Can J Anaesth"},{"issue":"7","key":"pone.0246123.ref023","article-title":"Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020","volume":"26","author":"ZD Guo","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"pone.0246123.ref024","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1164\/rccm.202006-2309OC","article-title":"Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery","volume":"202","author":"NT Gaeckle","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0246123.ref025","doi-asserted-by":"crossref","first-page":"010344","DOI":"10.7189\/jogh.10.010344","article-title":"Fighting COVID-19 with water","volume":"10","author":"G Lauc","year":"2020","journal-title":"J Glob Health"},{"issue":"3","key":"pone.0246123.ref026","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0668.2007.00469.x","article-title":"How far droplets can move in indoor environments\u2014revisiting the Wells evaporation-falling curve","volume":"17","author":"X Xie","year":"2007","journal-title":"Indoor Air"},{"issue":"1","key":"pone.0246123.ref027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13613-020-00653-z","article-title":"The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing","volume":"10","author":"K Wang","year":"2020","journal-title":"China. Ann Intensive Care"},{"issue":"2","key":"pone.0246123.ref028","first-page":"202","article-title":"Breathing patterns 1. Normal Subjects","volume":"84","author":"MJ Tobin","year":"1983","journal-title":"Chest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T16:26:15Z","timestamp":1613147175000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246123"}},"subtitle":[],"editor":[{"given":"Sreekumar","family":"Othumpangat","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,12]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0246123","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.14.20102517","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,12]]}}}